Immunome

Immunome Announces Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19

EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) announced that it recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for IMM-BCP-01, a three-antibody …

Immunome Announces Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19 Read More